Bionano Genomics, Inc. (BNGO)
NASDAQ: BNGO · Real-Time Price · USD
3.720
-0.050 (-1.33%)
At close: May 23, 2025, 4:00 PM
3.770
+0.050 (1.34%)
After-hours: May 23, 2025, 6:47 PM EDT
Bionano Genomics Stock Forecast
Stock Price Forecast
According to 3 professional analysts, the 12-month price target for Bionano Genomics stock ranges from a low of $4.00 to a high of $10. The average analyst price target of $7.33 forecasts a 97.04% increase in the stock price over the next year.
Price Target: $7.33 (+97.04%)
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for Bionano Genomics stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Dec '24 | Jan '25 | Feb '25 | Mar '25 | Apr '25 | May '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 | 1 | 2 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 3 | 3 | 3 | 3 | 3 | 3 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 3 | 3 | 3 | 3 | 4 | 5 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Maxim Group | Maxim Group | Hold → Strong Buy Upgrades $8 | Hold → Strong Buy | Upgrades | $8 | +115.05% | May 20, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Initiates $10 | Strong Buy | Initiates | $10 | +168.82% | Apr 9, 2025 |
| Scotiabank | Scotiabank | Hold Maintains $1 → $4 | Hold | Maintains | $1 → $4 | +7.53% | Apr 2, 2025 |
| Ladenburg Thalmann | Ladenburg Thalmann | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Nov 15, 2024 |
| BTIG | BTIG | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Sep 10, 2024 |
Financial Forecast
Revenue This Year
30.94M
from 30.78M
Increased by 0.53%
Revenue Next Year
34.10M
from 30.94M
Increased by 10.22%
EPS This Year
-8.45
from -88.13
EPS Next Year
-4.05
from -8.45
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | 32.0M | 36.2M | 106.7M |
| Avg | 30.9M | 34.1M | 103.7M |
| Low | 29.4M | 32.0M | 99.6M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | 4.1% | 17.1% | 212.9% |
| Avg | 0.5% | 10.2% | 204.0% |
| Low | -4.5% | 3.6% | 192.1% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | -6.30 | -3.21 | -0.08 |
| Avg | -8.45 | -4.05 | -0.08 |
| Low | -10.05 | -5.02 | -0.08 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | - | - | - |
| Avg | - | - | - |
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.